1. Home
  2. TBPH vs BKSY Comparison

TBPH vs BKSY Comparison

Compare TBPH & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • BKSY
  • Stock Information
  • Founded
  • TBPH 2013
  • BKSY 2013
  • Country
  • TBPH United States
  • BKSY United States
  • Employees
  • TBPH N/A
  • BKSY N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • TBPH Health Care
  • BKSY Technology
  • Exchange
  • TBPH Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • TBPH 699.0M
  • BKSY 699.0M
  • IPO Year
  • TBPH N/A
  • BKSY N/A
  • Fundamental
  • Price
  • TBPH $14.75
  • BKSY $18.88
  • Analyst Decision
  • TBPH Strong Buy
  • BKSY Strong Buy
  • Analyst Count
  • TBPH 4
  • BKSY 5
  • Target Price
  • TBPH $23.00
  • BKSY $29.00
  • AVG Volume (30 Days)
  • TBPH 284.3K
  • BKSY 2.0M
  • Earning Date
  • TBPH 11-10-2025
  • BKSY 11-06-2025
  • Dividend Yield
  • TBPH N/A
  • BKSY N/A
  • EPS Growth
  • TBPH N/A
  • BKSY N/A
  • EPS
  • TBPH 0.26
  • BKSY N/A
  • Revenue
  • TBPH $77,205,000.00
  • BKSY $104,662,000.00
  • Revenue This Year
  • TBPH $79.82
  • BKSY $15.43
  • Revenue Next Year
  • TBPH N/A
  • BKSY $34.03
  • P/E Ratio
  • TBPH $59.49
  • BKSY N/A
  • Revenue Growth
  • TBPH 24.49
  • BKSY N/A
  • 52 Week Low
  • TBPH $7.90
  • BKSY $6.15
  • 52 Week High
  • TBPH $15.34
  • BKSY $33.20
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 58.51
  • BKSY 38.96
  • Support Level
  • TBPH $14.11
  • BKSY $19.43
  • Resistance Level
  • TBPH $15.34
  • BKSY $21.46
  • Average True Range (ATR)
  • TBPH 0.42
  • BKSY 2.18
  • MACD
  • TBPH 0.06
  • BKSY -0.90
  • Stochastic Oscillator
  • TBPH 63.55
  • BKSY 2.27

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: